MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer
En‐Chi Hsu(Palo Alto University), Tanya Stoyanova(Palo Alto University)
Cited by 32
Related Papers
Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signaling
|Genes & Development|2012|149
Oncogene-mediated metabolic gene signature predicts breast cancer outcome
|npj Breast Cancer|2021|62
Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer
|Proceedings of the National Academy of Sciences|2016|49
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas
|Cell Reports Medicine|2024|29